Long-Term Persistence of Seroprotection by Hepatitis B Vaccination in Healthcare Workers of Southern Italy

Authors

Giuseppe Grosso1, Antonio Mistretta1,*, Stefano Marventano1, Roberta Ferranti1, Luisa Mauro1, Rosario Cunsolo2, Lidia Proietti3, Mariano Malaguarnera4
1G.F. Ingrassia Department, Section of Hygiene and Public Health, University of Catania, [email protected], Italy
2Rosario Cunsolo, Vittorio Emanuele Hospital of Catania Health Direction, Italy
3Department of Internal Medicine and Systemic Diseases, University of Catania, Italy
4The Great Senescence Research Center, University of Catania, Ospedale Cannizzao, Italy
*Corresponding Author: G.F. Ingrassia Department, Section of Hygiene and Public Health, University of Catania, Via Santa Sofia 87, 95123, [email protected], Italy. Tel: +39-953782182. Fax: +39-953782177. Email: [email protected]

Hepatitis Monthly:Vol. 12, issue 9; 6025
Published online:Sep 04, 2012
Article type:Research Article
Received:Nov 22, 2011
Accepted:Jul 28, 2012
How to Cite:Grosso G, Mistretta A, Marventano S, Ferranti R, Mauro L, et al. Long-Term Persistence of Seroprotection by Hepatitis B Vaccination in Healthcare Workers of Southern Italy. Hepat Mon. 2012;12(9):6025. doi: https://doi.org/10.5812/hepatmon.6025

Abstract

Background:

The impact of hepatitis B virus (HBV) vaccination campaigns on HBV epidemiology needs to be evaluated, in order to assess the long-term immunity offered by vaccines against HBV.

Objectives:

To evaluate the current status of anti-HBV vaccine coverage among healthcare workers (HCWs) in Southern Italy, and to determine the long-term persistence of antibodies to hepatitis B surface antigens (anti-HBs) in such a cohort of subjects.

Patients and Methods:

A longitudinal, retrospective seroepidemiological survey was conducted among 451 HCWs, who were working at or visiting, the Occupational Health Department of a city hospital, in Catania, Italy, between January 1976 and December 2010.

Results:

At the 30-year follow-up (mean follow-up 10.15 5.96 years, range 0.74-30), 261 HCWs had detectable anti-HBs titers indicating a persistence of seroprotection of 89.4% (out of 292 anti-HBs positive results, three months after vaccination). An inadequate vaccination schedule was the strongest predictor of antibody loss during follow-up (OR = 8.37 95% CI: 5.41-12.95, P < 0.001). A Kaplan-Maier survival curve revealed that the persistence of anti-HBs 30 years after vaccination, was 92.2% for high responders, while it was only 27.3% for low responders (P = 0.001).

Conclusions:

A good level of seroprotection persisted in 57.9% of the subjects after 30 years. Factors related to this immunization status confirmed the importance of vaccinating HCWs early in their careers and ensuring an adequate vaccination schedule. However, with particular reference to the low rate of hepatitis B vaccine coverage among HCWs in Southern Italy, the implementation of a new educational intervention as part of an active vaccination program is needed.

Highlights

Full Text

Full text is available in PDF

Copyright

© 2012, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

30
Sep
2011

Epidemiological Impact of Mandatory Vaccination against Hepatitis B in Italian Young Adults

Marcello Campagna,
Andrea Siddu,
Angelo Meloni,
Claudia Murru,
Giuseppina Masia,
Rosa Cristina Coppola

Campagna M, Siddu A, Meloni A, Murru C, Masia G, et al. Epidemiological Impact of Mandatory Vaccination against Hepatitis B in Italian Young Adults. Hepat Mon. 2011;11(9):. doi: https://doi.org/10.5812/kowsar.1735143X.723

26
Jul
2016

Coverage and Long-Term Immunogenicity of Hepatitis B Vaccine in Healthcare Workers

Omid Aminian,
Maryam Moaven Saidi,
Khosro Sadeghniiat Haghighi,
Nazanin Izadi

Aminian O, Moaven Saidi M, Sadeghniiat Haghighi K, Izadi N. Coverage and Long-Term Immunogenicity of Hepatitis B Vaccine in Healthcare Workers. Arch Clin Infect Dis. 2016;11(4):e35758. doi: https://doi.org/10.5812/archcid.35758

12
Jan
2014

Serum Levels of Anti-Hepatitis B Surface Antibody Among Vaccinated Population Aged 1 to 18 Years in Ahvaz City Southwest of Iran

Reza Norouzirad,
Abdol Hussein Shakurnia,
Mohammad-Ali Assarehzadegan,
Amirarsalan Serajian,
Mehdi Khabazkhoob

Norouzirad R, Shakurnia AH, Assarehzadegan M, Serajian A, Khabazkhoob M. Serum Levels of Anti-Hepatitis B Surface Antibody Among Vaccinated Population Aged 1 to 18 Years in Ahvaz City Southwest of Iran. Hepat Mon. 2014;14(1):e13625. doi: https://doi.org/10.5812/hepatmon.13625

1
May
2014

Prevalence of Hepatitis B Virus Seromarkers in Young Adults Vaccinated at Birth; Impact on the Epidemiology of Hepatitis B Infection in Iran

Hiva Saffar,
Abolghasem Ajami,
Mohammed Jafar Saffar,
Jalil Shojaei,
Maryam Sotudeh-Anvari,
Kiarash Shams-Esfandabad
,et al.

Saffar H, Ajami A, Saffar MJ, Shojaei J, Sotudeh-Anvari M, et al. Prevalence of Hepatitis B Virus Seromarkers in Young Adults Vaccinated at Birth; Impact on the Epidemiology of Hepatitis B Infection in Iran. Hepat Mon. 2014;14(5):e17263. doi: https://doi.org/10.5812/hepatmon.17263

7
Nov
2015

Persistence of Anti-HBs Among Palestinian Medical Students After 18 - 22 Years of Vaccination: A Cross-Sectional Study

Kamal Dumaidi,
Amer Al-Jawabreh

Dumaidi K, Al-Jawabreh A. Persistence of Anti-HBs Among Palestinian Medical Students After 18 - 22 Years of Vaccination: A Cross-Sectional Study. Hepat Mon. 2015;15(11):e29325. doi: https://doi.org/10.5812/hepatmon.29325

More by these authors

Giuseppe GrossoPubMedScholar
Antonio MistrettaPubMedScholar
Stefano MarventanoPubMedScholar
Roberta FerrantiPubMedScholar
Luisa MauroPubMedScholar
Rosario CunsoloPubMedScholar
Lidia ProiettiPubMedScholar
Mariano MalaguarneraPubMedScholar
Share
Cited by
Metrics